Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Cholesterol",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release Full lipoprotein profiling service from
Randox Laboratories, which we summarised at the time by saying "As the incidence of cardiovascular disease (CVD) is rising, it is becoming more and more important to assess risk factors for CVD, to reduce the incidence and mortality of the
disease".
A few weeks before,
we featured the news release Cholesterol - the good, the bad and the ugly from
Randox Laboratories: "HDL (the good), LDL (the bad) and sdLDL (the ugly) cholesterol tests are now available from Randox as direct clearance methods for fully automated clinical chemistry analysers".
In August 2007, we covered the news from Randox Laboratories
concerning its Randox direct sd LDL measurement
- take a look at Quantitative detection of sd LDL cholesterol
which says: "The Randox direct sd LDL measurement is fully automated, saving time and labour costs and gives quantitative sdLDL values, that will enable treatment optimisation".
Take a look also at the news release from Santaris Pharma, Development of the first microRNA medicine,
as well as VTT spins-off Zora Biosciences from VTT Technical Research Centre of Finland,
and Biomarkers are 'medical tool of the future' from Medical Research Council (MRC).
See also:
Cerenis forms scientific advisory board
(March 2007)
Privately-held pharmaceutical company developing novel HDL therapies to treat cardiovascular and other metabolic diseases announces appointments to its new scientific advisory board
Getting to heart of coronary artery disease
(February 2007)
An international consortium has been launched to tackle coronary artery disease (CAD) using the latest scientific tools
Analysis of the European phytosterols market
(May 2006)
Frost and Sullivan valued the total European phytosterols market to be worth $184.6 million in 2005, and estimates this to reach $395.2 million in 2012
Improved HDL cholesterol for clinical chemistry
(January 2005)
Method provides improved assay performance for HDL cholesterol testing with low interference from endogenous triglyceride and reduced reactivity to LDL
New MD comes at time of growth
(October 2004)
David Hawksworth, has been appointed managing director of Oxford Biosensors to oversee the next phase of development of Multisense, its point of care (POC) cholesterol analyser
Cholesterol analyser on show at AACC
(May 2004)
Cardiac risk test enables doctors and nurses to obtain test results quickly and easily, without the delay and inefficiency of using a central laboratory
Durable GC column for trans fat applications
(May 2004)
A long-lasting gas chromatography (GC) column has been designed specifically for efficient, reliable analysis of trans fatty acid ("trans fat") content in food
Low cost PoC diagnostics
(December 2003)
Healthcare professionals will be able to use the rapid low cost test to aid the diagnosis of medical conditions, without having to measure each parameter individually
Analysis of chromium in waters using voltammetry
(October 2002)
Jonathan Bruce, applications manager for Metrohm UK, provides this detailed introduction to analysis of chromium in waters
Analysis of arterial plaque formation
(April 2002)
Use of FT-IR imaging system to study lipid build-up in coronary arteries described in this new application note